1. Home
  2. ATCX vs IRIX Comparison

ATCX vs IRIX Comparison

Compare ATCX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATCX

Atlas Critical Minerals Corporation Common Stock

N/A

Current Price

$5.50

Market Cap

23.8M

Sector

N/A

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.04

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCX
IRIX
Founded
2016
1989
Country
Brazil
United States
Employees
13
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
23.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ATCX
IRIX
Price
$5.50
$1.04
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.75
N/A
AVG Volume (30 Days)
33.1K
161.5K
Earning Date
03-16-2023
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
$827,667.00
$3.07
Revenue Next Year
$166.45
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.39
$0.87
52 Week High
$14.01
$1.65

Technical Indicators

Market Signals
Indicator
ATCX
IRIX
Relative Strength Index (RSI) 48.42 38.17
Support Level $5.32 $0.99
Resistance Level $6.46 $1.20
Average True Range (ATR) 0.68 0.06
MACD 0.04 0.01
Stochastic Oscillator 48.21 38.21

Price Performance

Historical Comparison
ATCX
IRIX

About ATCX Atlas Critical Minerals Corporation Common Stock

Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: